Skip to content

Clinical trials

Cholangiocarcinoma trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Sweden Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20192
20201
20211
20221
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed2
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Elevar Therapeutics1
Fore Biotherapeutics1
Incyte Corporation1
Jazz Pharmaceuticals1
Karolinska University Hospital1
Maastricht University1
Maastricht University Medical Center1
PCI Biotech AS1
Region Skane1
Region Stockholm1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Carcinoma, Hepatocellular4
Bile Duct Neoplasms2
Biliary Tract Neoplasms2
Cholangitis, Sclerosing2
Breast Neoplasms1
Fallopian Tube Neoplasms1
Gallbladder Neoplasms1
Gastrointestinal Stromal Tumors1
Glioma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.